About Progestrade (CLONE)
Overview
Progestrade (CLONE) is a name that appears in our records as a potential clone of a legitimate broker, but with no verifiable independent presence. The official domain listed is http://www.progestrade.com/, yet our checks found no active website or social media footprint, which is a significant red flag for any financial service provider.
As of our review, there are no regulatory licences on file for this entity, and the country of registration is unknown. This lack of basic corporate and regulatory information makes it impossible to verify the legitimacy of the operations behind the name. For traders, this means there is no established authority to turn to in case of disputes or misconduct.
Regulatory Status
Our records show that Progestrade (CLONE) holds no licences from any financial regulator. The licence count is zero, and we have no record of any regulatory body overseeing its activities. This is a critical concern because regulated brokers must meet strict standards regarding client fund segregation, transparency, and conduct.
Without a licence, there is no independent oversight, and traders have no recourse through regulatory channels if something goes wrong. The absence of regulation is often a hallmark of high-risk or fraudulent operations, and in this case, the 'CLONE' designation further amplifies the risk.
Website and Online Presence
The official domain, http://www.progestrade.com/, is listed in our records, but when we attempted to access it, we found no verifiable website or social-media presence. This is unusual for any financial firm, as even small brokers typically have at least a basic web presence to attract clients.
The lack of a functional website means there is no public information about account types, trading platforms, instruments, or fees. This absence of transparency is a major warning sign, as legitimate brokers are usually eager to showcase their offerings and build trust with potential clients.
Risk Assessment
FXCanary's Scam Risk Score for Progestrade (CLONE) is 55 out of 100, which is rated as 'Elevated'. This score is driven by two key risk flags: no verified regulatory licence on file, and no verifiable website or social-media presence. Both factors contribute to a high level of uncertainty and risk for any trader considering this entity.
In our assessment, the combination of an unregulated status and a non-existent online footprint makes it highly likely that this is a fraudulent operation, possibly impersonating a legitimate broker. We strongly advise traders to avoid any dealings with this entity until it can provide verifiable regulatory credentials and a transparent operational presence.
Conclusion
In summary, Progestrade (CLONE) presents a clear case of a high-risk financial entity. With no regulation, no verifiable website, and a designation as a clone, the potential for fraud is significant. Traders should exercise extreme caution and consider this entity as unsuitable for any form of investment.
We recommend that anyone who has been approached by this broker or has seen its name in promotional materials should verify the legitimacy of any claims independently. The absence of reliable information is itself a strong indicator that this is not a trustworthy operation.
Overview compiled by FXCanary from regulatory records and public data. full Progestrade (CLONE) review